An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
NCT06129812
·
clinicaltrials.gov ↗
COMPLETED
Status
1132
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Neoadjuvant
Interventions
DRUG:
Neoadjuvant treatment
Sponsor
Seoul National University Hospital